610
SSGJ-610-HH-I-01
Phase 1 small_molecule active
Quick answer
610 for add-on Maintenance Treatment of Patients With Severe Eosinophilic Asthma is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- add-on Maintenance Treatment of Patients With Severe Eosinophilic Asthma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active